1. Home
  2. ATYR vs MEC Comparison

ATYR vs MEC Comparison

Compare ATYR & MEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • MEC
  • Stock Information
  • Founded
  • ATYR 2005
  • MEC 1945
  • Country
  • ATYR United States
  • MEC United States
  • Employees
  • ATYR N/A
  • MEC N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • MEC Industrial Specialties
  • Sector
  • ATYR Health Care
  • MEC Industrials
  • Exchange
  • ATYR Nasdaq
  • MEC Nasdaq
  • Market Cap
  • ATYR 330.7M
  • MEC 324.5M
  • IPO Year
  • ATYR 2015
  • MEC 2019
  • Fundamental
  • Price
  • ATYR $3.97
  • MEC $14.35
  • Analyst Decision
  • ATYR Strong Buy
  • MEC Strong Buy
  • Analyst Count
  • ATYR 6
  • MEC 3
  • Target Price
  • ATYR $18.60
  • MEC $20.67
  • AVG Volume (30 Days)
  • ATYR 2.0M
  • MEC 121.3K
  • Earning Date
  • ATYR 03-13-2025
  • MEC 03-04-2025
  • Dividend Yield
  • ATYR N/A
  • MEC N/A
  • EPS Growth
  • ATYR N/A
  • MEC 226.32
  • EPS
  • ATYR N/A
  • MEC 1.24
  • Revenue
  • ATYR $235,000.00
  • MEC $581,604,000.00
  • Revenue This Year
  • ATYR $1,387.23
  • MEC $4.91
  • Revenue Next Year
  • ATYR $873.22
  • MEC $1.59
  • P/E Ratio
  • ATYR N/A
  • MEC $11.57
  • Revenue Growth
  • ATYR N/A
  • MEC N/A
  • 52 Week Low
  • ATYR $1.42
  • MEC $12.50
  • 52 Week High
  • ATYR $4.66
  • MEC $23.02
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 56.81
  • MEC 42.98
  • Support Level
  • ATYR $2.98
  • MEC $13.71
  • Resistance Level
  • ATYR $3.73
  • MEC $15.37
  • Average True Range (ATR)
  • ATYR 0.40
  • MEC 0.76
  • MACD
  • ATYR 0.04
  • MEC 0.00
  • Stochastic Oscillator
  • ATYR 80.32
  • MEC 60.08

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

Share on Social Networks: